國家衛生研究院 NHRI:Items for Author

Year

Loading year class tree, please wait....

Items for Author "Shiah, HS"

Return to Browse by Author

Showing 34 items.

Collection	Date	Title	Relation
[張俊彥] 期刊論文	2002	A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer	-
[夏和雄(1996-2012)] 期刊論文	2002-02	Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23	-
[彭汪嘉康(1996-2007)] 期刊論文	2002-05	Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients	-
[彭汪嘉康(1996-2007)] 期刊論文	2004-12	Prognostic implications of the expression of erbB2, topoisomerase II alpha and thymidylate synthase in metastatic gastric cancer after fluorouracil-based therapy	-
[彭汪嘉康(1996-2007)] 期刊論文	2005-08-01	alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma	-
[彭汪嘉康(1996-2007)] 期刊論文	2005-12	Pulmonary embolism after transcatheter arterial chemoembolization	-
[張俊彥] 會議論文/會議摘要	2005-12	Induction of cell death by a novel selenophene derivative, D-501036, in human cancer cell lines	-
[陳立宗] 期刊論文	2006-03	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	-
[陳立宗] 期刊論文	2006-05	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	-
[夏和雄(1996-2012)] 期刊論文	2006-10	Inhibition of cell growth and nuclear factor-kappa B activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503	-
[夏和雄(1996-2012)] 期刊論文	2006-10	Abrogation of skin disease in lupus-prone MRL/Fas(lpr) mice by means of a novel tylophorine analog	-
[劉滄梧] 期刊論文	2006-11	Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma	-
[張俊彥] 會議論文/會議摘要	2006-11	D-501036, a novel selenophene-base triheterocycle derivative exhibits potent in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation	-
[郭靜娟] 期刊論文	2007-01	D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation	-
[夏和雄(1996-2012)] 期刊論文	2007-03-01	Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036	-
[張俊彥] 期刊論文	2007-11-15	Tamoxifen accelerates proteasomal degradation of O-6-methylguanine DNA methyltransferase in human cancer cells	-
[陳立宗] 會議論文/會議摘要	2009-05-20	Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)	-
[陳立宗] 期刊論文	2009-11	Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer	-
[彭汪嘉康(1996-2007)] 期刊論文	2009-12	Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent	-
[夏和雄(1996-2012)] 會議論文/會議摘要	2011-04	Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas	-
[蘇益仁(2002-2015)] 期刊論文	2011-10	Novel feedback inhibition of surface antigen synthesis by Mammalian Target of Rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy	-
[張俊彥] 期刊論文	2011-12-15	Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors	-
[陳立宗] 會議論文/會議摘要	2012-02	Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy	-
[陳立宗] 期刊論文	2013-01	Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma	-
[夏和雄(1996-2012)] 會議論文/會議摘要	2013-05	Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma	-
[陳立宗] 期刊論文	2015-03	Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients	-
[陳立宗] 期刊論文	2015-05	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer	-
[蔡慧珍] 會議論文/會議摘要	2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	-
[姜乃榕] 期刊論文	2017-05	A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy	-
[其他] 會議論文/會議摘要	2019-05	Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients	-
[陳立宗] 期刊論文	2020-04	Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours	-
[陳立宗] 期刊論文	2021-03	A phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma	-
[陳立宗] 期刊論文	2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	-
[陳立宗] 期刊論文	2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	-

Loading...

Category

Year

Items for Author "Shiah, HS"